S&P takes Vita Capital VI mortality bond off negative watch as Covid-19 outlook improves
The first CAT bond rating action caused by the Covid-19 coronavirus pandemic has now been resolved and reverted, as S&P Global Ratings affirmed Swiss Re’s late 2015 Vita Capital VI Limited (Series 2015-1) transaction and removed it from a negative watch. The mortality CAT bond which featured a single $100 million tranche of Class A notes issued by Vita Capital VI Ltd., one of only a handful still in-force at the time of the pandemic, had its ‘BB (sf)’ rating placed on CreditWatch with negative implications by S&P at the beginning of April. With the risk period set to end on December 31st 2020 and due to the fact mortality from the pandemic has affected older age groups the worst, and these only contribute a small proportion to the mortality index value calculation for the Vita Capital cat bond, and deaths stabilising in the UK, S&P feels the risk of this mortality cat bond being triggered has now greatly reduced.